Pang Yao
Overview
Explore the profile of Pang Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng P, Clarke C, Iona A, Wright N, Yao P, Chen Y, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077736
Monitoring bone mineral density (BMD) in adults is critical for early detection of osteoporosis and prevention of fracture, for which quantitative ultrasound (QUS) is a good non-invasive tool. We examined...
2.
Guo Y, Mazidi M, Wright N, Yao P, Wang B, Niu Y, et al.
Environ Sci Technol
. 2025 Mar;
PMID: 40033795
Nonoptimal ambient temperatures (i.e., cold and heat) are leading environmental determinants of major diseases worldwide, but the underlying pathological mechanisms are still poorly understood. We used distributed-lag nonlinear models to...
3.
Wang B, Pozarickij A, Mazidi M, Wright N, Yao P, Said S, et al.
Nat Commun
. 2025 Feb;
16(1):1869.
PMID: 39984443
Proteomics offers unique insights into human biology and drug development, but few studies have directly compared the utility of different proteomics platforms. We measured plasma levels of 2168 proteins in...
4.
Yu H, Zhang J, Qian F, Yao P, Xu K, Wu P, et al.
Diabetes Care
. 2025 Jan;
48(3):381-389.
PMID: 39749935
Objective: Peripheral artery disease (PAD) is a significant complication of type 2 diabetes (T2D), yet the association between plasma proteomics and PAD in people with T2D remains unclear. We aimed...
5.
Mazidi M, Wright N, Yao P, Kartsonaki C, Millwood I, Fry H, et al.
Eur J Epidemiol
. 2024 Nov;
39(11):1229-1240.
PMID: 39578299
Plasma proteomics could enhance risk prediction for multiple diseases beyond conventional risk factors or polygenic scores (PS). To assess utility of proteomics for risk prediction of ischemic heart disease (IHD)...
6.
Iona A, Yao P, Pozarickij A, Kartsonaki C, Said S, Wright N, et al.
Commun Biol
. 2024 Oct;
7(1):1327.
PMID: 39406990
Adiposity is an established risk factor for multiple diseases, but the causal relationships of different adiposity types with circulating protein biomarkers have not been systematically investigated. We examine the causal...
7.
Zhu K, Li R, Yao P, Yu H, Pan A, Manson J, et al.
Nat Food
. 2024 Sep;
6(1):47-57.
PMID: 39333296
Healthy dietary patterns have been linked to a decreased risk of chronic diseases. However, it remains uncertain whether proteomic signatures can reflect proteome response to healthy diet patterns, and whether...
8.
Argentieri M, Xiao S, Bennett D, Winchester L, Nevado-Holgado A, Ghose U, et al.
Nat Med
. 2024 Aug;
30(9):2450-2460.
PMID: 39117878
Circulating plasma proteins play key roles in human health and can potentially be used to measure biological age, allowing risk prediction for age-related diseases, multimorbidity and mortality. Here we developed...
9.
Zhong J, Zhang Y, Zhu K, Li R, Zhou X, Yao P, et al.
Lancet Healthy Longev
. 2024 Aug;
5(8):e542-e551.
PMID: 39106873
Background: Social determinants of health (SDHs) are the primary drivers of preventable health inequities, and the associations between SDHs and health outcomes among individuals with type 2 diabetes remain unclear....
10.
Wu T, Ke Y, Li Y, Wu Z, Lv J, Yu C, et al.
Heart
. 2024 Jul;
110(20):1208-1215.
PMID: 39084708
Background: Integration of large proteomics and genetic data in population-based studies can provide insights into discovery of novel biomarkers and potential therapeutic targets for cardiometabolic diseases (CMD). We aimed to...